SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-12-003874
Filing Date
2012-04-04
Accepted
2012-04-04 10:56:36
Documents
5
Period of Report
2012-05-16
Effectiveness Date
2012-04-04

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2208662zdef14a.htm DEF 14A 695298
2 G463432.JPG g463432.jpg GRAPHIC 12470
3 G404820.JPG g404820.jpg GRAPHIC 9567
4 G17342BCI001.GIF g17342bci001.gif GRAPHIC 50982
5 G17342BCI002.GIF g17342bci002.gif GRAPHIC 45631
  Complete submission text file 0001047469-12-003874.txt   860391
Mailing Address 550 HILLS DRIVE BEDMINSTER NJ 07921
Business Address 550 HILLS DRIVE BEDMINSTER NJ 07921 (908) 450-5300
NPS PHARMACEUTICALS INC (Filer) CIK: 0000890465 (see all company filings)

IRS No.: 870439579 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23272 | Film No.: 12740615
SIC: 2836 Biological Products, (No Diagnostic Substances)